Therefore, SR‐B1 acts as a host factor that promotes SARS‐CoV‐2 entry and may help explain viral tropism, identify a possible molecular connection between COVID‐19 and lipoprotein metabolism, and highlight SR‐B1 as a potential therapeutic target to interfere with SARS‐CoV‐2 infection.97 The gene discussed is SCARB1; the disease is COVID-19.